Bee Venom by Deep Blue Health — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

45 Servings

Non-Nutrient/Non-Botanical Product Type

50% Evidence Coverage

Supplement Facts — Evidence Check

Bee Venom

25 mcg

Glucosamine Sulphate

500 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 500mg

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take two or three capsules daily as a dietary food supplement or as professionally advised.

⚠️ Warnings & Precautions

Caution: Not suitable for those with allergies to bee products. This product can cause severe allergic reactions.

🧪 Formulation Notes

Joint health

Deep Blue Health Bee Venom with glucosamine sulphate is a potent formula which supports joint mobility function. Ingredients: Each capsule contains 25 mcg of Bee Venom; 500mg of Glucosamine sulphate; and encapsulating materials.

No artificial flavours, colours or preservatives.

Laboratory tested. RMP Number 8888. Made in New Zealand Premium quality guaranteed

Additional Information

Bee Series 500mg x 90 capsules

Store below 30 degrees C in a dry place

TAPS PP9947

New Zealand Made GMP Good Manufacturing New Zealand Practice Export Quality From New Zealand

Product Details

UPC / SKU 9 421026 536907

DSLD Entry Date 2024-06-20

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Deep Blue Health

DSLD ID 311565

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →